Background: Red blood cell distribution width (RDW) is a novel prognostic marker that reflects oxidative stress and chronic inflammation in patients with cardiovascular disease. Diabetes mellitus increases oxidative stress and vascular inflammation, which accelerate atherosclerosis. However, the relationship between RDW and long-term outcome in diabetic patients with coronary artery disease (CAD) is unclear.
ed blood cell distribution width (RDW) is a measurement of the variability in size of circulating erythrocytes. RDW is obtained routinely in standard complete blood cell counts (CBCs) without additional costs and has been used in the differential diagnosis of anemia. 1 Increased RDW indicates the presence of anisocytosis, which is related to impaired erythropoiesis and erythrocyte degradation, reflecting chronic inflammation and a high level of oxidative stress. [2] [3] [4] Although the underlying biological mechanisms remain unclear, RDW is being recognized as a global marker of chronic inflammation and oxidative stress. Recent studies have reported elevated RDW as strongly being associated with poor clinical outcomes in patients with heart failure, 5-7 coronary artery disease (CAD), 8,9 pulmonary hypertension, 10 and peripheral artery disease. 11 It is well known that morbidity and mortality of patients with CAD and diabetes mellitus (DM) remains high despite current advances in drug therapy and revascularization techniques. 12-15 Accordingly, it is important to identify factors that might contribute to such high morbidity and mortality in CAD patients with DM. In general, patients with DM show high levels of chronic inflammation and oxidative stress, which play key roles in the progression of atherosclerotic diseases. [16] [17] [18] [19] A recent report demonstrated that elevated RDW was associated with the incidence of both micro-and macrovascular complications in diabetic patients without marked vascular complications. 20 Diabetic patients with CAD display a higher incidence of cardiovascular events than non-diabetic patients, even after revascularization. 21, 22 Despite the poor prognosis, no useful clinical tools are currently available to stratify mortality risk within diabetic patients with CAD. Nobel biomarkers for predicting future cardiovascular events are needed. However, no studies have investigated the relationship between RDW and mortality in diabetic patients with CAD. This is the first study in which an increased RDW was associated with increased mortality in diabetic patients with CAD treated with percuta-Impact of RDW in DM Patients After PCI neous coronary intervention (PCI).
Methods

Study Population
This was a single-center, observational study. We enrolled 560 consecutive diabetic patients who underwent elective PCI for stable CAD in our institution from January 2000 to December 2007. Indications for PCI were objective evidence of myocardial ischemia (positive sign on stress test) or ischemic symptoms associated with significant angiographic stenosis (>75% stenosis). Patients with hemodialysis were excluded because chronic immune activation can arise from contact activation of immune cells by dialysis membranes, from frequent episodes of infection, or both, 23 which might affect RDW as a different mechanism from non-hemodialysis patients. Baseline blood analyses were measured on the day of PCI after overnight fasting. Demographic data (including age, sex, coronary risk factors such as blood pressure, lipid profiles, fasting blood glucose, smoking habits, family history of CAD, and medication at the time of PCI) and comorbidities (prior myocardial infarction and prior coronary artery bypass graft) were also recorded. All patients provided written consent for the PCI procedure, and the study protocols were approved by the institutional review board.
Definition of Coronary Risk Factors
Patients ≥65 years old were defined as being elderly. DM was defined as an elevated fasting plasma glucose concentration >126 mg/dl or hemoglobin A1c (HbA1c) >6.5%, or current treatment with insulin or oral hypoglycemic agents. Hypertension was defined as systolic blood pressure >140 mmHg or diastolic blood pressure >90 mmHg, or treatment with antihypertensive drugs. Dyslipidemia was defined as low-density lipoprotein cholesterol >140 mg/dl, high-density lipoprotein <40 mg/dl, or treatment with lipid-lowering drugs. We defined impaired estimated glomerular filtration rate (eGFR) as eGFR <60 ml · min -1 · 1.73 m -2 . To calculate eGFR, the following formula was used: eGFR (ml · min -1 · 1.73 m -2 )=194×(serum creatinine) -1.094 ×(age) -0.287 (×0.739 if female). 24 Anemia was defined as a hemoglobin level <12.0 g/dl in women and <13.0 g/dl in men, based on the World Health Organization definition. 25 A high level of high-sensitivity C-reactive protein (hs-CRP) was defined as a value equal to or greater than the median hs-CRP value (ie, 1.01 mg/L in this cohort). Impaired left ventricular (LV) function was defined as LV ejection fraction <60%.
Classification of RDW
Baseline RDW values were measured after overnight fasting using an XE-5000 automated hematology analyzer (Sysmex, Kobe, Japan). To evaluate associations between RDW and clinical outcome, patients were divided into 2 groups according to the median baseline RDW (ie, 13.1% in this cohort). Patients with a RDW ≥13.1% were classified into the high RDW group and those with a RDW <13.1% were classified into the low RDW group.
Clinical Outcomes
The end-point of this study was the incidence of all-cause death. Cardiac death was defined as death caused by myocardial infarction, heart failure and sudden death. Clinical outcome data were collected until 31 December 2008. Clinical event data were fully collected during the follow-up period for all patients by reviewing clinical charts, telephone contacts and questionnaires. The mean follow-up period was 3.9 years (range, 2.3-5.5 years).
Statistical Analysis
Continuous variables are presented as mean (interquartile ranges). Comparisons between high and low RDW groups were performed using the Student's t-test or the Mann-Whitney Utest for continuous variables, and the χ2 test or Fisher's exact test for categorical variables, as appropriate. Correlations between RDW and other CBC parameters including hemoglobin, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), MCH concentration (MCHC) were assessed by using Spearman's rank correlations test for these continuous variables. Kaplan-Meier curves were constructed to compare cumulative survival between the high and low RDW groups using the log-rank test and generalized Wilcoxon test for survival analysis. Cox proportional hazards modeling was used to determine the association between incidence of all-cause mortality and RDW. The following clinical variables were used in univariate models: elderly, sex, presence of hypertension, systolic blood pressure, diastolic blood pressure, presence of dyslipidemia, total cholesterol, high-density lipoprotein cholesterol, triglycerides, HbA1c, presence of anemia, MCV, MCH, MCHC, current smoking status, family history of CAD, history of coronary CABG, presence of anemia, hs-CRP, presence of low eGFR, presence of multivessel disease, impaired LV function and baseline medications. To identify variables to enter into a multivariate model, forward stepwise multivariate analysis with an entry criterion of P<0.15 was performed. Furthermore, another multivariate model for all-cause mortality was conducted in order to take into account the effect of anemia on the association between RDW and all-cause mortality. Values of P<0.05 were considered significant. All statistical analyses were performed using JMP ® 8 software (SAS Institute, Cary, NC, USA).
Results
Baseline Characteristics
Baseline characteristics and medications are shown in Table 1 . The mean age was 66.6 years and 80% of patients were male. Patients in the high RDW group were significantly older, more likely to have dyslipidemia, had a prior history of CABG, lower ejection fraction, lower hemoglobin level and higher hs-CRP level than patients in the low RDW group. HbA1c and individual values from lipid profiles were comparable between the groups. No significant differences in baseline medication were identified between the groups.
Correlations Between RDW and Other CBC Parameters
In the present study population, RDW correlated negatively with hemoglobin (r=-0.17, P=0.002), hematocrit (r=-0.11, P=0.047), MCV (r=-0.18, P=-0.002), MCH (r=-0.30, P<0.001) and MCHC (r=-0.29, P<0.001).
Clinical Outcomes
Twenty-nine patients (5.2%) died, including 14 deaths from cardiac causes (myocardial infarction, n=4; heart failure, n=5; and sudden death, n=5) during the follow-up period ( Table 2) .
The cumulative incidence of all-cause death was significantly higher in the high RDW group than in the low RDW group (Log-rank, P=0.0015; Wilcoxon, P=0.0178) (Figure) . Results of uni-and multivariate analyses for all-cause death are shown in Table 3A . After stepwise analysis, variables for inclusion in multivariate analysis were elderly status, high hs-CRP, impaired LV function and high RDW. In multivariate Cox pro-TSUBOI S et al.
portional hazards modeling, high RDW was significantly associated with an increased incidence of all-cause death (hazard ratio (HR), 2.56; and 95% confidence interval (CI), 1.12-6.62; P=0.025) after adjustment, as shown in Table 3B (model 1). The association between RDW and the risk of all-cause mortality was significant even after inclusion of the presence of anemia as a fixed independent variable (Table 3B, model 2).
The cumulative incidence of deaths specifically from cardiac causes was also significantly higher in the high RDW group than in the low RDW group (Log-rank, P<0.001; Wilcoxon, P=0.0023). After stepwise analysis, variables for inclusion in multivariate analysis were impaired LV function and high RDW. In multivariate Cox proportional hazards modeling, high RDW was significantly associated with an increased incidence of cardiac death (HR, 16.2; 95% CI, 2.09-124.7; P=0.008) after adjustment. ACE-I, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; CABG, coronary artery bypass graft surgery; DAPT, dual antiplatelet therapy; DBP, diastolic blood pressure; EF, ejection fraction; eGFR, estimated glomerular filtration rate; HDL-C, high density lipoprotein cholesterol; HbA1c, hemoglobin A1c; hs-CRP, high sensitivity C-reactive protein; MCV, mean corpuscular volume; MI, myocardial infarction; OHA, oral hypoglycemic agents; RDW, red blood cell distribution width; SBP, systolic blood pressure; T-Cho, total cholesterol. 
Discussion
The main finding in the present study was that increased RDW at baseline was significantly associated with increased risk of all-cause and cardiac mortality in diabetic patients who underwent elective PCI. The association remained significant even after adjustment for other independent variables. The present study results suggest that paying attention to RDW might provide valuable clinical information for long-term risk stratification among diabetic CAD patients without incurring additional costs, because RDW is available as part of a CBC. RDW has been used in the differential diagnosis of anemia. Previous studies have demonstrated an association between anemia and mortality. 26, 27 It is known that there are inverse correlations between RDW and hemoglobin levels and MCV. 1, 7 In the present study, RDW negatively correlated with hemoglobin levels, hematocrit and MCV. Previous studies have demonstrated that the strong association between RDW and poor clinical outcomes was independent from the presence of anemia or hemoglobin levels. 5-9 Indeed, the association between RDW and all-cause mortality was significant even after adjusted for anemia in the present study.
Increased RDW indicates the presence of anisocytosis, an increased variability in red blood cell size called caused by ineffective erythrocyte production. Increased RDW is commonly found when nutritional deficiencies (eg, iron, folate or vitamin B12) exist. In contrast, increased RDW is also related to oxidative stress and the release of cytokines in response to inflammation. Oxidative stress directly damages erythrocytes and leads to shortened erythrocyte survival, resulting in elevated RDW. 28 Semba et al investigated the effect of serum antioxidants on RDW in community-dwelling elder women. In that study, selenium, as a marker of antioxidant levels, was an independent predictor of RDW, suggesting that antioxidant status might influence RDW and play a role in the relationship between increased RDW and worsened clinical prognosis. 29 Lippi et al demonstrated a correlation between RDW and indices of inflammation, such as elevated erythrocyte sedimentation rate (ESR) and hs-CRP, identifying strong, graded increases in both ESR and hs-CRP across RDW quartiles. 30 In addition, increased RDW is associated with increased levels of pro-inflammatory cytokines such as tumor necrosis factor α and interleukin 6. 29 These cytokines attenuate the activity of erythropoietin and cause production of ineffective red blood cells, leading to elevated RDW. 3,4,31 RDW thus might reflect multiple pathophysiologic processes including nutritional deficiencies, ineffective erythrocyte production and shortened erythrocyte lifespan via chronic inflammation and oxidative stress, which might result in increasing morbidity and mortality of cardiovascular diseases. This concept is supported by our finding of a close relationship between RDW and mortality, observed independently from hs-CRP, as a well-established biomarker of inflammation.
RDW has been reported as a strong prognostic marker in patients with heart failure. 5-7 However, the relationship between RDW and clinical outcome in patients with stable CAD was not fully eliminated. In a post-hoc analysis of the Cholesterol and Recurrent Events (CARE) study, Tonelli et al demonstrated a relationship between RDW and clinical outcome in patients with a prior history of myocardial infarction (3-20 months after onset) without any symptoms of heart failure. In that study, with a mean follow-up period of 6 years, the risk for all-cause mortality was significantly increased in patients with a RDW >13.8% (highest quartile) compared to those with a RDW <12.6% (lowest quartile) (HR, 1.78; 95% CI, 1.28-2.47). A graded relationship between RDW and death also remained. In addition, patients in the highest RDW quartiles also have an increased risk of fatal or non-fatal myocardial infarction compared with those in the lowest quartile (HR, 1.56; 95% CI, 1.17-2.08). 8 Wang et al investigated the relationship between RDW and short-term outcome in a Chinese ACS population. RDW that was ≥13.3% (highest quartile) at baseline was associated with a 1-month cardiac mortality (HR, 2.116; 95% CI, 1.427-3.137; P<0.001) compared with a RDW <12.2% (lowest quartile). 32 The results of these studies suggesting RDW as a useful prognostic marker in patients with CAD are consistent with the present study findings. Our study extended the significance of RDW in CAD patients to diabetic patients.
Among patients with CAD, those with DM have a higher incidence of subsequent cardiovascular events than those without DM. 33,34 This is also true in patients who undergo coronary revascularization. 16,35, 36 Patel et al investigated the mortality among patients in community-based studies of older adults and also analyzed subgroups, including diabetic patients, in a meta-analysis. In the subgroup of participants with DM, a graded increase in mortality risk was seen according to RDW values. 37 Malandrino et al demonstrated an association between RDW and micro-and macrovascular complications in diabetic populations in the United States with the Third National Health and Nutrition Examination Survey (NHANES III). In that study, higher RDW values were associated with an increased risk of developing cardiovascular disease and nephropathy in diabetic patients after adjusting for clinical variables, and the rate of participants with at least 1 diabetic complication significantly increased across RDW quartiles. 20 Chronic inflammation and oxidative stress play important roles in the progression of atherosclerosis that leads to cardiovascular disease. 38- 40 To evaluate the inflammatory state, hs-CRP, one of the most well-established biomarkers of chronic inflammation, has been available and useful for predicting future cardiovascular events in daily clinical practice. 41, 42 Previous studies have reported that oxidative stress is associated with the pathogenesis of cardiovascular disease. 43, 44 However, Figure. Kaplan-Meier estimates of survival for all-cause mortality. The all-cause mortality rate was significantly higher in the high RDW group compared with the low RDW group. RDW, red blood distribution width. TSUBOI S et al.
we do not have clinical biomarkers that allow simple, direct measurement of oxidative stress. RDW might offer a comprehensive marker that reflects oxidative stress and inflammation. This is the first study to suggest RDW as a predictive marker for mortality in diabetic patients with CAD. We believe RDW has the potential to gain wide use in daily clinical practice.
Study Limitations
Some limitations in the present study must be considered. First, this was a single center, retrospective study with a small sample size. Residual confounding factors might thus have affected the results, regardless of the adjusted analysis. Second, no information is available regarding nutritional deficiencies (iron, folate or vitamin B12) closely associated with RDW. Another possible limitation is the absence of information regarding the duration of DM. The relationship between RDW and diabetic complications appears independent of the duration of DM. 20 Further studies are needed to clarify the mechanisms underlying the relationship between RDW and mortality.
Conclusions
In conclusion, increased RDW at baseline is associated with all-cause and cardiac mortality rates in diabetic patients after PCI. RDW might be useful as a marker for risk stratification in diabetic patients with CAD because this value is easily determined as part of the standard CBC. Variables for inclusion in multivariate analysis were high RDW, high hs-CRP, elderly and impaired EF in model 1.
Variables for inclusion in multivariate analysis were high RDW, high hs-CRP, elderly, impaired EF and anemia in model 2. CAD, coronary artery disease; CI, confidence interval; HR, hazard ratio. Other abbreviations as in Table 1 .
